Evidence map›Paper›PMID 26600700›Full record

ArticleIndian journal of palliative care

Is Karnofsky Performance Status Correlate with Better Overall Survival in Palliative Conformal Whole Brain Radiotherapy? Our Experience.

Alessia Reali, Simona Allis, Andrea Girardi, Roberta Verna, Lavinia Bianco, Maria Grazia Ruo Redda

Open access · diamondAbstract read
In one paragraph

Article in Indian journal of palliative care. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Alessia RealiDepartment of Oncology, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano, Italy.
Simona AllisDepartment of Oncology, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano, Italy.
Andrea GirardiDepartment of Oncology, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano, Italy.
Roberta VernaDepartment of Oncology, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano, Italy.
Lavinia BiancoDepartment of Oncology, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano, Italy.
Maria Grazia Ruo ReddaDepartment of Oncology, Radiation Oncology Unit, University of Turin, S. Luigi Hospital, Orbassano, Italy.
University of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimBrain metastases (BMs) are a common event in the progression of many human cancers. The aim of this study was to evaluate the potential prognostic factors for the clinical identification of a subgroup of patients that could benefit from whole brain conformal radiotherapy (WBRT). MATERIALS AND

methodsFrom January 2010 to February 2014, 80 patients with a diagnosis of BMs underwent WBRT at our Radiation Oncology Department, San Luigi Hospital, Italy. Among them, 36 medical records were retrospective reviewed. Gender, age, Karnofsky performance status (KPS), number of BMs on computed tomography and/or magnetic resonance images, presence or absence of perilesional edema, presence or absence of necrosis pattern, and histology of primary tumor were analyzed. Univariate and multivariate analyses were performed.

resultsIn our cohort of patients, significant prognostic factors for 20 months overall survival was KPS> 70, while a statistical trend (P = 0.098) was registered regarding primary breast.

conclusionWBRT can be still considered a standard and effective treatment in patients with BMs. High KPS and breast cancer primary tumor seem to be useful parameters for characterize a subgroup of patients with more favorable prognosis.

Indexed as

Brain metastasesKarnofsky performance statusPrognostic factorsWhole brain radiotherapy

Identifiers

PMID26600700
PMCPMC4617039
OpenAlexW2264045520

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.